Drug Topics

NOVEMBER 23, 2022

Take a look back at our most popular diabetes coverage for 2022.

503

503

Pharmacy Times

NOVEMBER 23, 2022

Study finds early career workers were more likely to disengage during the pandemic, such as by showing a lack of interest or becoming cynical about work.

145

145

Drug Topics

NOVEMBER 23, 2022

In a recent study, racial minorities of an older age with non-classic cutaneous manifestations were more often to present with juvenile idiopathic inflammatory myopathies after COVID-19 infection.

490

490

Pharmacy Times

NOVEMBER 23, 2022

For patients with opioid use disorder, medication-assisted treatment programs are a clinically effective approach.

132

132

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

NOVEMBER 23, 2022

The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.

247

247

Pharmacy Times

NOVEMBER 23, 2022

As a new year approaches, pharmacists have so much to look back on and be grateful for, and a world of opportunity in front of them. Here are a few things to be ready for right away in 2023.

131

131

European Pharmaceutical Review

NOVEMBER 23, 2022

The US Food and Drug Administration (FDA) has approved Hemgenix (etranacogene dezaparvovec), the first gene therapy for adults with Haemophilia B (congenital Factor IX deficiency) who currently use Factor IX prophylaxis therapy, or have current or historical life-threatening haemorrhage, or have repeated, serious spontaneous bleeding episodes. Standard treatment for the condition involves replacing the missing or deficient clotting factor to improve the body’s ability to stop bleeding and promot

FDA 128

FDA Adverse Reactions 128

PharmaVoice

NOVEMBER 23, 2022

With their latest personnel moves, these life sciences companies are preparing for major business shifts.

130

130

Fierce Healthcare

NOVEMBER 23, 2022

Google rolls out search features that aim to make it easier to sign up for Medicaid, Medicare. pminemyer. Wed, 11/23/2022 - 11:12.

126

126

Pharmacy Times

NOVEMBER 23, 2022

CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.

Vaccines 123

Vaccines 123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Pharma

NOVEMBER 23, 2022

Sporting a $3.5M price tag, CSL and uniQure's hemophilia B gene therapy crosses FDA finish line. zbecker. Wed, 11/23/2022 - 10:10.

FDA 120

FDA 120

Pharmacy Times

NOVEMBER 23, 2022

Patients with cystic fibrosis may benefit from a 1000 mg vitamin C supplement, which can increase the bioavailability of other antioxidants.

123

123

Fierce Healthcare

NOVEMBER 23, 2022

ACA signups top 3M since start of open enrollment, a 17% bump compared to last year. rking. Wed, 11/23/2022 - 11:58.

119

119

Pharmacy Times

NOVEMBER 23, 2022

IPX203 is a novel, oral formulation of carbidopa/levodopa extended-release capsules.

FDA 123

FDA 123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

NOVEMBER 23, 2022

On a roll, Takeda's dengue vaccine shifts into FDA's fast review lane. kdunleavy. Wed, 11/23/2022 - 09:35.

Vaccines 112

Vaccines FDA 112

Pharmacy Times

NOVEMBER 23, 2022

The adeno-associated virus vector-based gene therapy is the first gene therapy to be approved by the FDA for hemophilia B.

FDA 122

FDA 122

pharmaphorum

NOVEMBER 23, 2022

Each person living with a rare disease has a unique experience of their condition, but all will have faced similar challenges. They have suffered from an overwhelming diagnosis experience that has left them feeling misunderstood, isolated, and desperate for someone to help them connect symptoms and make sense of the sheer volume of information. Many will also face barriers to care, where access to specialists is limited and often geographically out of reach.

Communication 112

Communication 112

Fierce Healthcare

NOVEMBER 23, 2022

There's an 'arms race' in health tech. Who could be the next M&A target? hlandi. Wed, 11/23/2022 - 17:55.

111

111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

European Pharmaceutical Review

NOVEMBER 23, 2022

The European Medicines Agency (EMA) has established the Quality Innovation Expert Group (QIG) to aid innovative approaches for the development, manufacture and quality control (QC) of medicines, including new technologies, digitalisation, novel materials and novel devices for patients in the European Union (EU). The QIG, set up in September 2022, is composed of eight members with backgrounds in chemical, biological quality assessment and Good Manufacturing Practice (GMP) inspections, who report

Documentation 111

Documentation 111

Fierce Healthcare

NOVEMBER 23, 2022

Chaotic work conditions during COVID helped foster clinician burnout. fdiamond. Wed, 11/23/2022 - 13:06.

111

111

Fierce Pharma

NOVEMBER 23, 2022

Senator aims to cut biosimilar 'red tape' with proposal to eliminate interchangeable status. kdunleavy. Wed, 11/23/2022 - 07:18.

109

109

Pharma Tutor

NOVEMBER 23, 2022

Klotho : A hope for the acute kidney injury-diabetes comorbidity. admin. Thu, 11/24/2022 - 10:12. About Authors. Ajinath Kale, Anil Bhanudas Gaikwad*. Laboratory of Molecular Pharmacology, Department of Pharmacy, Birla Institute of Technology and Science Pilani, Pilani Campus, Rajasthan, India. *anil.gaikwad@pilani.bits-pilani.ac.in.

105

105

Pharmaceutical Technology

NOVEMBER 23, 2022

The US Food and Drug Administration (FDA) has granted approval for CSL Behring’s adeno-associated virus vector-based gene therapy, Hemgenix (etranacogene dezaparvovec), to treat haemophilia B (congenital Factor IX deficiency) in adult patients. The treatment is indicated for usage in such individuals who use Factor IX prophylaxis treatment, or have an existing or historical life-threatening haemorrhage, or recurrent, serious episodes of sudden bleeding.

FDA 105

FDA Labelling 105

STAT

NOVEMBER 23, 2022

Five months after a media investigation revealed that hospitals were feeding Meta sensitive patient information through a tracking tool on their websites, prominent systems like UPMC, Advocate Aurora, and Duke Health are still contending with the resulting legal action. The Markup and STAT News co-published an investigation in June that found one-third of Newsweek’s top 100 U.S. hospitals were using a tracker called Meta Pixel that sends Meta, formerly known as Facebook, data whenever pat

Hospitals 105

Hospitals 105

ISPE

NOVEMBER 23, 2022

ISPE Represented at PIC/S 50th Anniversary Event. Trudy Patterson. Wed, 11/23/2022 - 06:50. iSpeak Blog. iSpeak. ISPE Represented at PIC/S 50th Anniversary Event. Robert W. Tribe. 23 November 2022. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) celebrated its 50th anniversary at a special symposium in Dublin, Ireland on 4 October 2022. Since the first meeting of the PIC Committee in 1972, PIC/S has come a long way!

Documentation 98

Documentation FDA Communication 98

STAT

NOVEMBER 23, 2022

When Ken Duckworth was a child, his family didn’t talk about mental health, especially not his father’s bipolar disorder. It was an untouchable topic, but Duckworth knew his father shouldn’t be seen as a lost cause. Instead, his father and others like him might actually have critical expertise on how to navigate the world with mental illness — expertise they gained not through books and studying but through lived experience.

98

98

DiversifyRx

NOVEMBER 23, 2022

ACOs are one of the many organizations that pharmacy owners can partner with to bring better patient care and increase revenues. In this blog, our good friend Kris Rhea from Biolyte will help us dive into ACOs and their impact on the independent pharmacy owner. About Kris. Kris has been working in the independent pharmacy business for about a decade now and is passionate about the community service model that independent pharmacy is all about.

Health and Personal Care Stores 98

Health and Personal Care Stores Independent Pharmacies Patient Care Immunization 98

STAT

NOVEMBER 23, 2022

The U.S. has two separate health care systems: one for people who aren’t incarcerated, and one for people behind bars. Since 2006, physician and researcher Emily Wang has been working to integrate the two. “There’s really no glue, no connection between these health care systems,” Wang said. “When you have two million individuals cycling in and out of two disparate health care systems, your first thought — and I was a young physician at the time —

98

98

Fierce Healthcare

NOVEMBER 23, 2022

How a new fertility business hopes to disrupt the traditional investor approach and preserve clinician decision-making. agliadkovskaya. Wed, 11/23/2022 - 13:34.

98

98

STAT

NOVEMBER 23, 2022

Yale and Harvard Law Schools recently announced they would no longer participate in U.S. News & World Report’s (USNWR) flawed ranking system, followed closely by additional schools. The nation’s medical schools need to follow their lead. Why? The USNWR ranking system is in direct opposition to medical schools’ goal of educating a well-trained, diverse, and culturally competent medical workforce.

Medical Schools 98

Medical Schools 98

The Guardian - Pharmaceutical Industry

NOVEMBER 23, 2022

Hemgenix frees patients from repeated treatments but initial cost makes it most expensive medicine in the world US drug regulators have approved a one-off gene-therapy treatment for adults with the genetic blood disorder hemophilia B that frees patients from repeated treatments but costs $3.5m a dose, making it the most expensive medicine in the world.

FDA 98

FDA 98

STAT

NOVEMBER 23, 2022

LAS VEGAS — Google has honed its message for hospital systems wary of moving their data to its cloud services: We are going to make this very easy for you. At the HLTH conference in Las Vegas this month, the company emphasized products and services that reduce the technical challenges health systems face as they look to modernize their technology infrastructure.

Patient Care 98

Patient Care Hospitals 98

Fierce Healthcare

NOVEMBER 23, 2022

Chutes & Ladders—Geisinger's CIO quietly exits; Amedisys CEO ushered out after low earnings. aburky. Wed, 11/23/2022 - 14:09.

98

98